Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein‐Barr virus latent membrane protein‐1: coordinate up‐regulation of peptide transporters and HLA‐class I antigen expression
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Group I Burkitt lymphoma (BL) lines retaining the original BL tumor cell phenotype are unable to present endogenously expressed antigens to HLA class I‐restricted cytotoxic T cells (CTL) but can be recognized if the relevant HLA class I/peptide epitope complex is reconstituted at the cell surface by exogenous addition of synthetic target peptide. Endogenous antigen‐processing function is restored in BL lines that have undergone Epstein‐Barr virus (EBV)‐induced drift in culture to the group III phenotype typically displayed by EBV‐transformed lymphoblastoid cell lines (LCL) of normal B cell origin. We compared group I versus group III cells for their expression of proteasome components, transporter proteins and HLA‐class I antigens, all of which are thought to be involved in the endogenous antigen processing pathway. By Western blot analysis, there were not consistent differences in the low molecular mass protein subunits of proteasomes (lmp)‐2, lmp‐7 and δ, although the mb‐1 proteasome subunit was regularly present at higher levels in group I BL lines relative to group III lines or LCL. By contrast there were marked differences in the expression of peptide transporter‐associated proteins (Tap), with down‐regulation of Tap‐1 and Tap‐2 in 8/8 and 7/8 group I BL lines, respectively. Surface levels of HLA class I antigens were also consistently lower in group I cells; this was not associated with an intracellular accumulation of free HLA heavy chains, such as is seen in the Tap‐deficient T2 processing‐mutant line, but instead reflected a reduced rate of HLA class I synthesis in group I cells. Analysis of EBV gene transfectants of the B lymphoma lines BJAB and BL41 showed that the virus‐encoded latent membrane protein‐1 (LMP1), which is one of several EBV antigens expressed in group III but not in group I cells, was uniquely able to up‐regulate expression both of the Tap proteins and HLA class I. Furthermore, this was accompanied by a restoration of antigen‐processing function as measured by the ability of these cells to present an endogenously expressed viral antigen to CTL. These effects of LMP1 were similar to those induced in the same cell lines by interferon‐γ treatment. The results implicate both Tap and HLA class I expression as factors limiting the antigen‐processing function of BL cells, and suggest that the accessibility of other EBV‐associated malignancies to CTL surveillance may be critically dependent upon their LMP1 status.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
Cited by
Marincola, F. M., Jaffee, E. M., Hicklin, D. J., & Ferrone, S. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60911-6 · Cited by 1,174
Does the Immune System See Tumors as Foreign or Self?
Pardoll, D. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141135 · Cited by 753
HUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTION
Rickinson, A. B., & Moss, D. J. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.405 · Cited by 747
Self-citationMechanisms of Immune Evasion by Tumors
Drake, C. G., Jaffee, E., & Pardoll, D. M. (2006) · Advances in Immunology · doi:10.1016/s0065-2776(06)90002-9 · Cited by 688
Saveanu, L., Carroll, O., Lindo, V., Del Val, M., Lopez, D., Lepelletier, Y., Greer, F., Schomburg, L., Fruci, D., Niedermann, G., et al. (2005) · Nature Immunology · doi:10.1038/ni1208 · Cited by 481
X-Linked Lymphoproliferative Disease
Parolini, S., Bottino, C., Falco, M., Augugliaro, R., Giliani, S., Franceschini, R., Ochs, H. D., Wolf, H., Bonnefoy, J.-Y., Biassoni, R., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.337 · Cited by 477
The Global Landscape of EBV-Associated Tumors
Shannon-Lowe, C., & Rickinson, A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00713 · Cited by 459
Self-citationRecognition of peptide–MHC class I complexes by activating killer immunoglobulin-like receptors
Stewart, C. A., Laugier-Anfossi, F., Vély, F., Saulquin, X., Riedmuller, J., Tisserant, A., Gauthier, L., Romagné, F., Ferracci, G., Arosa, F. A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503594102 · Cited by 406
Optimization of the MHC Class I Peptide Cargo Is Dependent on Tapasin
Williams, A. P., Peh, C. A., Purcell, A. W., McCluskey, J., & Elliott, T. (2002) · Immunity · doi:10.1016/s1074-7613(02)00304-7 · Cited by 353
Johnson, L. A., Heemskerk, B., Powell, D. J., Cohen, C. J., Morgan, R. A., Dudley, M. E., Robbins, P. F., & Rosenberg, S. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6548 · Cited by 343
Bottino, C., Falco, M., Parolini, S., Marcenaro, E., Augugliaro, R., Sivori, S., Landi, E., Biassoni, R., Notarangelo, L. D., Moretta, L., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.3.235 · Cited by 310
Epstein–Barr virus and Burkitt lymphoma
Brady, G., MacArthur, G. J., & Farrell, P. J. (2008) · Postgraduate Medical Journal · doi:10.1136/jcp.2007.047977 · Cited by 301
Soluble Tapasin Restores MHC Class I Expression and Function in the Tapasin-Negative Cell Line .220
Lehner, P. J., Surman, M. J., & Cresswell, P. (1998) · Immunity · doi:10.1016/s1074-7613(00)80474-4 · Cited by 294
Taylor, G. S., Long, H. M., Haigh, T. A., Larsen, M., Brooks, J., & Rickinson, A. B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3746 · Cited by 69
Self-citation
Metadata
- Authors
- Rowe, M., Khanna, R., Jacob, C. A., Argaet, V., Kelly, A., Powis, S., Belich, M., Groom‐Carter, D., Lee, S., Burrows, S. R., Trowsdale, J., Moss, D. J., & Rickinson, A. B.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1995-05
- Volume
- 25
- Issue
- 5
- Pages
- 1374-1384
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2052621715
- Cited by
- 191
- References
- 1
- FWCI
- 4.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.